Passive Immunization with Lingo-1 Polyclonal Antiserum Afforded Neuroprotection and Promoted Functional Recovery in A Rat Model of Spinal Cord Injury

Jun Lv,Ru-xiang Xu,Xiao-dan Jiang,Xin Lu,Yi-quan Ke,Ying-qian Cai,Mou-xuan Du,Changchen Hu,Yu-xi Zou,Ling-sha Qin,Yan-jun Zeng
DOI: https://doi.org/10.1159/000290043
2010-01-01
NeuroImmunoModulation
Abstract:LINGO-1 (leucine-rich repeat and Ig domain-containing, Nogo receptor-interacting protein) is an important component of the NgR receptor complex involved in RhoA activation and axon regeneration. The authors report on passive immunization with LINGO-1 polyclonal antiserum, a therapeutic approach to overcome NgR-mediated growth inhibition after spinal cord injury (SCI). The intrathecally administered high-titer rabbit-derived antiserum can be detected around the injury site within a wide time window; it blocks LINGO-1 in vivo with high molecular specificity. In this animal model, passive immunization with LINGO-1 antiserum significantly decreased RhoA activation and increased neuronal survival. Adult rats immunized in this manner show recovery of certain hindlimb motor functions after dorsal hemisection of the spinal cord. Thus, passive immunotherapy with LINGO-1 polyclonal antiserum may represent a promising repair strategy following acute SCI.
What problem does this paper attempt to address?